Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2023-05-18 00:00:00 ET · period of report 2023-05-16 · accession 0000919574-23-003408 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2023-05-18 | 2023-05-16+ | BLFS | Casdin Partners Master Fund, L.P. | 10% | P - Purchase | $21.26 | +75.0K | 45.0K | New | +$1.60M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $.001 per share | 2023-05-16 | P | A | 15,000 | $20.19 | 15,000 | I See footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $20.1643 to $20.2385. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. (F2) The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. |
| 2 | Common | Common Stock, par value $.001 per share | 2023-05-18 | P | A | 30,000 | $21.76 | 75,027 | I See footnote | — | — | (F2) The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. |
| 3 | Common | Common Stock, par value $.001 per share | 2023-05-17 | P | A | 30,027 | $21.30 | 45,027 | I See footnote | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions within the range of $20.98 to $21.8582. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. (F2) The securities are owned directly by a client of Casdin Capital, LLC ("Casdin Capital") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, the investment adviser to such client; (ii) Casdin Partners GP, LLC ("Casdin GP"), the general partner of such client, and (iii) Eli Casdin, the managing member of Casdin Capital and Casdin GP. |